Oral deucrictibant for on-demand treatment of hereditary angioedema attacks: a phase 3, multicentre, randomised, double-blind, placebo-controlled crossover trial. (linkinghub.elsevier.com)

Authors: Riedl MA … Cohn DM Journal: The Lancet Published: 2026-10-08 DOI: https://doi.org/10.1016/S0140-6736(26)01296-1